US President Donald Trump signed an executive order to strengthen research and care for women and girls at every stage of life. First Lady Melania Trump led the initiative, which covers prevention, diagnosis, treatment and care.
The order establishes a White House Women’s Health Task Force to coordinate a comprehensive federal approach to health needs from infancy and childhood through pregnancy, menopause and aging. It also supports policy and regulatory changes intended to ensure prevention, diagnosis and treatment are tailored to each stage of life.
The Secretary of Health and Human Services and the Director of the National Institutes of Health are directed to establish a Women’s Health Division within the NIH. The division is intended to coordinate research, address gaps in scientific understanding and speed the use of discoveries to improve health outcomes.
The order rescinds initiatives launched by the previous administration. The White House said the new approach would go beyond research and prioritize applying its findings in clinical care for women and girls.
The order identifies research needs in areas including cardiovascular disease, cancer, stroke, Alzheimer’s disease, autoimmune and inflammatory conditions, osteoporosis, mental health, chronic pain, endometriosis, fibroids, polyendocrine metabolic ovary syndrome (PMOS), infertility, maternal health, menopause, neurological disorders and aging.
The White House also cited other administration measures. In November 2025, the Food and Drug Administration began removing broad and misleading black-box warnings from hormone replacement therapy products for menopause. Since TrumpRx.gov launched in February 2026, patients have saved more than $700 million on medicines, according to the administration.
The White House said 46 states have invested in maternal health, including telehealth, remote monitoring, obstetric workforce development and postpartum care. In May 2026, the administration launched Moms.gov, a resource for expectant and new mothers.
